Literature DB >> 35354045

Asthmatic bronchial smooth muscle increases rhinovirus replication within the bronchial epithelium.

Pauline Esteves1, Benoit Allard1, Alexis Celle1, Isabelle Dupin1, Elise Maurat1, Olga Ousova1, Matthieu Thumerel2, Jean-William Dupuy1, Thierry Leste-Lasserre1, Roger Marthan2, Pierre-Olivier Girodet2, Thomas Trian3, Patrick Berger2.   

Abstract

Rhinovirus (RV) infection of the bronchial epithelium is implicated in the vast majority of severe asthma exacerbations. Interestingly, the susceptibility of bronchial epithelium to RV infection is increased in persons with asthma. Bronchial smooth muscle (BSM) remodeling is an important feature of severe asthma pathophysiology, and its reduction using bronchial thermoplasty has been associated with a significant decrease in the exacerbation rate. We hypothesized that asthmatic BSM can play a role in RV infection of the bronchial epithelium. Using an original co-culture model between bronchial epithelium and BSM cells, we show that asthmatic BSM cells increase RV replication in bronchial epithelium following RV infection. These findings are related to the increased production of CCL20 by asthmatic BSM cells. Moreover, we demonstrate an original downregulation of the activity of the epithelial protein kinase RNA-activated (PKR) antiviral pathway. Finally, we identify a direct bottom-up effect of asthmatic BSM cells on bronchial epithelium susceptibility to RV infection.
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CCL20; CP: Immunology; PKR; eIF2α; epithelium; exacerbation; severe asthma

Mesh:

Year:  2022        PMID: 35354045     DOI: 10.1016/j.celrep.2022.110571

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  2 in total

Review 1.  Viral Infection and Airway Epithelial Immunity in Asthma.

Authors:  So Ri Kim
Journal:  Int J Mol Sci       Date:  2022-08-31       Impact factor: 6.208

2.  Increased airway smooth muscle cells in asthma: mechanisms and therapeutic prospects.

Authors:  Fabien Beaufils; Patrick Berger
Journal:  Ann Transl Med       Date:  2022-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.